PTCT
Ticker
PTC Therapeutics, Inc.
PTCT · Healthcare · PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children…PTC Therapeutics, Inc. (PTCT), in the Healthcare sector, has 59 disclosed filings on Paydirt over the trailing twelve months from 13 corporate insiders: 0 purchases and 59 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Oct 14 and filed Oct 16. The most active filer was Mark Elliott Boulding with 11 filings. Data as of Nov 7 2026.
Add to watchlistFilings, ttm
59
0 buys · 59 sells
Traders, ttm
13
13 insiders
Volume, ttmiDollar value disclosed in the window
$41.3M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Oct 14
Filed Oct 16
ADViAverage daily dollar volume
$125.1M
market data
Share price · 12M
$60.59 (-16.4%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $86.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
MBAll 15 filers
LGRecent filings
Michael SchmertzlerSALE
Director
$126K2,118 sh × $59.52
Exec Oct 14
Filed Oct 16 · 5:20 PM ET Michael SchmertzlerSALE Director $155K
2,447 sh × $63.38
Exec Oct 7
Filed Oct 9 · 5:20 PM ET Mark Elliott BouldingSALE EXEC. VP AND CLO $105K
1,638 sh × $64.03
Exec Oct 5
Filed Oct 7 · 5:20 PM ET Glenn Jr Md Phd SteeleSALE Director $782K
12,000 sh × $65.16
Exec Sep 30
Filed Oct 2 · 5:20 PM ET Michael SchmertzlerSALE Director $1.3M
19,624 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 5:20 PM ET Michael SchmertzlerSALE Director $1.3M
19,428 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 5:20 PM ET Michael SchmertzlerSALE Director $1.8M
24,390 sh across 3 lots
Exec Aug 26
Filed Aug 28 · 5:20 PM ET Michael SchmertzlerSALE Director $1.8M
24,309 sh across 4 lots
Exec Aug 19
Filed Aug 21 · 5:20 PM ET Mark Elliott BouldingSALE EXEC. VP AND CLO $133K
1,844 sh × $72.39
Exec Aug 17
Filed Aug 19 · 5:20 PM ET Matthew B. KleinSALE CHIEF EXECUTIVE OFFICER $706K
10,292 sh × $68.57
Exec Aug 4
Filed Aug 6 · 5:20 PM ET Pierre GravierSALE CHIEF FINANCIAL OFFICER $281K
3,494 sh × $80.35
Exec Jul 14
Filed Jul 16 · 5:20 PM ET Mary L. SmithSALE Director $1.4M
15,834 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 5:20 PM ET Neil Gregory AlmsteadSALE CHIEF TECHNICAL OPS OFFICER $222K
2,464 sh × $90.25
Exec Jul 9
Filed Jul 13 · 5:20 PM ET Neil Gregory AlmsteadSALE CHIEF TECHNICAL OPS OFFICER $4.0M
45,963 sh across 6 lots
Exec Jul 6
Filed Jul 8 · 5:20 PM ET Neil Gregory AlmsteadSALE CHIEF TECHNICAL OPS OFFICER $658K
7,718 sh × $85.26
Exec Jun 26
Filed Jun 30 · 5:30 PM ET Neil Gregory AlmsteadSALE CHIEF TECHNICAL OPS OFFICER $2.1M
24,781 sh across 3 lots
Exec Jun 24
Filed Jun 26 · 5:30 PM ET Neil Gregory AlmsteadSALE CHIEF TECHNICAL OPS OFFICER $1.9M
23,749 sh across 2 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Mark Elliott BouldingSALE EXEC. VP AND CLO $798K
10,153 sh across 3 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET Christine Marie UtterSALE SVP, CHIEF ACCOUNTING OFFICER $1.5M
19,686 sh × $75.56
Exec Jun 17
Filed Jun 22 · 5:30 PM ET Eric PauwelsSALE CHIEF BUSINESS OFFICER $1.6M
21,277 sh across 2 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET Mark Elliott BouldingSALE EXEC. VP AND CLO $170K
2,356 sh × $72.08
Exec May 15
Filed May 19 · 5:30 PM ET Matthew B. KleinSALE CHIEF EXECUTIVE OFFICER $868K
11,893 sh across 3 lots
Exec May 14
Filed May 15 · 5:30 PM ET Mark Elliott BouldingSALE EXEC. VP AND CLO $151K
1,900 sh × $79.31
Exec May 8
Filed May 12 · 5:30 PM ET Matthew B. KleinSALE CHIEF EXECUTIVE OFFICER $202K
2,850 sh × $70.91
Exec Apr 21
Filed Apr 23 · 5:30 PM ET Mark Elliott BouldingSALE EXEC. VP AND CLO $101K
1,443 sh × $69.75
Exec Apr 6
Filed Apr 8 · 5:30 PM ET